A Risk-Based Treatment Strategy for Non-Rhabdomyosarcoma Soft-Tissue Sarcomas in Young Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Risk-Based Treatment Strategy for Non-Rhabdomyosarcoma Soft-Tissue Sarcomas in Patients Younger Than 30 Years (ARST0332): A Children's Oncology Group Prospective Study
Lancet Oncol 2019 Nov 27;[EPub Ahead of Print], SL Spunt, L Million, YY Chi, J Anderson, J Tian, E Hibbitts, C Coffin, MB McCarville, RL Randall, DM Parham, JO Black, SC Kao, A Hayes-Jordan, S Wolden, F Laurie, R Speights, E Kawashima, SX Skapek, W Meyer, AS Pappo, DS HawkinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.